effectiveness of combination of cilostazol and aspirin in preventing thrombosis after interventional neuroradiology procedures

1、

influence of cilostazol on expression of platelet activation markers in aged acute cerebral infarction

西洛他唑对老年急性脑梗死患者血小板活化功能的影响

互联网摘选

2、

treatment of the ischemia of the lower extremities with cilostazol

西洛他唑治疗下肢缺血的疗效与安全性观察

互联网摘选

3、

pharmacokinetics of domestic cilostazol tablets in chinese healthy volunteers;

目的研究西洛他唑片在人体内的药动学。

互联网摘选

4、

studies on the preparation and dissolution of micronized cilostazol tablets

西洛他唑微粉化片剂的制备和溶出度测定

互联网摘选

5、

the effect of cilostazol on erectile function in diabetic rat model

西洛他唑对糖尿病模型大鼠勃起功能的影响

互联网摘选

6、

conclusion this novel triple antiplatelet regimen ( aspirin and clopidogrel combined with cilostazol) for pci patients is safe and more efficient than the dual antiplatelet therapy regimen ( clopidogrel and aspirin) in reducing mortality and incidence of mace in a short-term period.

结论PCI后应用氯吡格雷、阿司匹林和西洛他唑三联抗血小板治疗是安全的，与常规氯吡格雷和阿司匹林两联抗血小板治疗相比可显著降低近期死亡和MACE发生率，但还需随机临床试验证实。

互联网摘选

7、

aim to detect the dissolution rate of cilostazol tablets with sotax auto dissolution tester and its methodological validation.

目的以西洛他唑片为例，利用SOTAX自动溶出仪对溶出度方法作方法学验证。

互联网摘选

8、

objective to evaluate short-term efficacy and safety of triple antiplatelet regimen ( cilostazol combined with clopidogrel and aspirin) in treatment of patients with coronary heart disease ( chd) concomitant with ischemic cerebral vascular disease ( icvd) history after percutaneous coronary intervention ( pci).

目的探讨既往有缺血性脑血管事件发作史的冠心病患者行经皮冠状动脉介入治疗（PCI）后应用西洛他唑联合阿司匹林和氯吡格雷三联抗血小板治疗方案的近期疗效和安全性。

互联网摘选

9、

aim to examine the effects of a novel selective phosphodiesterase ( pde) type 3 inhibitors, cilostazol on superoxide free radicals ( o · 2) generation and calcium concentration ( i) in neutrophils.

目的研究新型磷酸二酯酶（PDE）3抑制剂西洛他唑（cilostazol）对中性粒细胞超氧自由基（O·2）和钙离子浓度（[Ca2+]i）的影响。

互联网摘选

10、

cilostazol is a kind of platelet aggregation inhibitors, and is often administrated orally in the treatment of stable angina cruris.

西洛他唑（Cilostazol）属于血小板凝集抑制剂，其口服主要用于治疗稳定性间歇性跛行。

互联网摘选

11、

reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the cilostazol for restenosis ( crest) trial

成功置入冠状动脉支架的患者应用西洛他唑治疗可以降低6个月资源占用和成本：来自西洛他唑治疗再狭窄（CREST）试验的结果

互联网摘选

12、

objective to evaluate short-term efficacy and safety of triple antiplatelet regimen ( cilostazol combined with clopidogrel and aspirin) in patients who underwent percutaneous coronary intervention ( pci).

目的评价冠状动脉介入治疗（PCI）后应用西洛他唑联合阿司匹林和氯吡格雷三联抗血小板治疗方案的近期疗效和安全性。

互联网摘选

13、

for leg pain, there is cilostazol that helps patients walk better.

对于有腿部疼痛的患者，西洛他唑（Cilostazol）可以让他们走路更舒服。

互联网摘选

14、

drugs; cilostazol, including 50 mg cilostazol per tablet;

实验药品：西洛他唑片，每片含西洛他唑50mg；

互联网摘选

15、

two groups of patients are given enalapril maleate tablets, pancreatic kallikrein enteric-coated tablets, the treatment group in the control group and on the basis of diabetes renal capsule, course of treatment for 60 days.

两组患者均给予马来酸依那普利片、胰激肽原酶肠溶片，治疗组在对照组基础上加用消渴肾安胶囊，疗程为60天。

互联网摘选

16、

objective in order to provide the scientific instructions for quality control and clinic, the qualities of pancreatic kallidinogenase enteric-coated tablets obtained from several pharmaceutical factories were evaluated.

目的对部分厂家的胰激肽原酶肠溶片的效价进行质量评价，为严格质量控制及临床选择用药提供科学的依据。

互联网摘选

17、

combined therapy of kallidinogenase and irbesartan for early period type 2 diabetic nephropathy of elderly patients verification of kininogen 1 as a serum molecular marker of proliferative vitreoretinopathy

厄贝沙坦联合胰激肽原酶治疗老年早期糖尿病肾病的观察激肽原1作为增生性玻璃体视网膜病变血清分子标志物的验证

互联网摘选

18、

the pancreatic kininogenase has been widely utilized as medicine, including declining the blood pressure and treating the diabetic nephropathy, cardiovascular ischemic and cerebrovascular complications.

胰激肽原酶具有广泛的药用价值，除降血压之外，还可以用于治疗糖尿病、肾病、改善肾脏功能，治疗心、脑血管疾病等。

互联网摘选

19、

conclusion: kallidinogenase is effective to some degree in the prevention and cure of senile diabetic nephropathy and diabetic macroangiopathy.

结论：胰激肽原酶对防治老年糖尿病肾病进展及糖尿病大血管病变有一定作用。

互联网摘选

20、

objective: to evaluate the efficacy and safety of the pancreatic kininogenase tablets in treating early stage diabetic nephropathy.

目的：评价胰激肽原酶片治疗早期糖尿病肾病患者的疗效和安全性。

互联网摘选